Bloom Energy's Slip: Why Wall Street Is Toning Down Its Enthusiasm Amidst High Hopes and Unanswered Questions
Major Clinical Setback: Harmony Biosciences' Genetic Disorder Drug Disappoints in Crucial Phase 3 Study